These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2495384)

  • 21. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.
    Kopf GS; Hammond GL; Geha AS; Elefteriades J; Hashim SW
    Circulation; 1987 Sep; 76(3 Pt 2):III132-6. PubMed ID: 3621536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are there guidelines for timing readministration of anticoagulation with marcumar in patients with artificial heart valves after intracerebral hemorrhage (stroke, subarachnoid hemorrhage, subdural hematoma)?].
    Kienast J; Ringelstein EB; Borggrefe M
    Internist (Berl); 1997 Jan; 38(1):83-5. PubMed ID: 9119665
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of the St. Jude Medical heart valve prosthesis. A two-year follow-up of 150 patients.
    Burckhardt D; Hoffmann A; Vogt S; Pfisterer M; Hasse J; Grädel E
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):432-8. PubMed ID: 6471892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticoagulation during pregnancy following an artificial heart valve replacement].
    Strecker T; Zimmermann I; Schlüter G; Feyrer R
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2116-9. PubMed ID: 19809961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late failure of porcine valve heterografts in children.
    Geha AS; Laks H; Stansel HC; Cornhill JF; Kilman JW; Buckley MJ; Roberts WC
    J Thorac Cardiovasc Surg; 1979 Sep; 78(3):351-64. PubMed ID: 470416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year follow up of the ATS mechanical heart valve.
    Emery RW; Krogh CC; Jones DJ; Nicoloff DM; Blake DP; Arom KV
    J Heart Valve Dis; 2004 Mar; 13(2):231-8. PubMed ID: 15086262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six years' experience with the Omnicarbon valve prosthesis.
    Otaki M; Kitamura N
    Cardiovasc Surg; 1993 Oct; 1(5):594-8. PubMed ID: 8076103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanical valve replacement in congenital heart disease.
    Fiane AE; Lindberg HL; Saatvedt K; Svennevig JL
    J Heart Valve Dis; 1996 May; 5(3):337-42. PubMed ID: 8793687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mitral and aortic valve replacement in childhood].
    Berg T; Keck EW
    Z Kardiol; 1984 Mar; 73(3):173-80. PubMed ID: 6719995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up to nine-years' experience with the Allcarbon prosthetic heart valve.
    Ho TH; Van Nguyen P; Phan PK; Pham VN
    J Heart Valve Dis; 2005 Jul; 14(4):512-7. PubMed ID: 16116878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac valve prostheses in children without anticoagulation.
    Pass HI; Sade RM; Crawford FA; Hohn AR
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):832-5. PubMed ID: 6727406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bj"ork-Shiley heart vales at the Bern University Hospital. Long-term follow-up of 12 to 23 years after mitral and aortic valve replacement in 503 patients].
    Stuber T; Kaufmann U; Kipfer B; Meier B
    Praxis (Bern 1994); 1999 Feb; 88(9):355-63. PubMed ID: 10191683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitral valve replacement with St. Jude Medical prosthesis and low-dose anticoagulation in patients aged over 50 years.
    Katircioglu SF; Yamak B; Ulus AT; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1998 Jul; 7(4):455-9. PubMed ID: 9697071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Late complications following Björk-Shiley and St. Jude Medical heart valve replacement].
    Horstkotte D; Körfer R; Budde T; Haerten K; Schulte HD; Bircks W; Loogen F
    Z Kardiol; 1983 May; 72(5):251-61. PubMed ID: 6880335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The On-X heart valve: mid-term results in a poorly anticoagulated population.
    Williams MA; van Riet S
    J Heart Valve Dis; 2006 Jan; 15(1):80-6. PubMed ID: 16480016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valve prostheses in children: a reassessment of anticoagulation.
    Sade RM; Crawford FA; Fyfe DA; Stroud MR
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):553-61. PubMed ID: 3352289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with aortic and mitral valve replacement in children.
    Williams WG; Pollock JC; Geiss DM; Trusler GA; Fowler RS
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):326-33. PubMed ID: 7464196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.